Oct 8, 2026 08:04AM
Oct 8, 2026 08:00AM
Sep 29, 2026 07:31AM
Sep 29, 2026 07:30AM
Sep 21, 2026 07:31AM
Sep 21, 2026 07:30AM
Sep 10, 2026 07:30AM Medicus Pharma publishes Phase 2 SkinJect study report
Sep 10, 2026 07:30AM
Sep 8, 2026 07:30AM
Sep 8, 2026 07:30AM
Aug 12, 2026 06:00PM
Jul 27, 2026 08:17AM
Jul 27, 2026 08:17AM
Jul 16, 2026 07:30AM Medicus Pharma gets FDA feedback and IRB nod for smaller Phase 2 trial
Jul 16, 2026 07:30AM
Jun 22, 2026 07:30AM
Jun 15, 2026 07:30AM
Jun 15, 2026 07:30AM
Jun 8, 2026 07:32AM
Jun 8, 2026 07:30AM
Jun 3, 2026 08:00AM Medicus Pharma Advances SkinJect® into Registrational Development for Gorlin Syndrome
May 28, 2026 08:06AM
May 28, 2026 08:00AM
May 14, 2026 04:30PM
May 6, 2026 07:30AM
May 6, 2026 07:30AM
May 1, 2026 02:30PM
Apr 27, 2026 07:39AM Medicus Pharma CEO meets with House lawmakers on rare disease treatment
Apr 27, 2026 07:30AM
Apr 27, 2026 07:30AM
Apr 17, 2026 07:31AM
Apr 17, 2026 07:30AM
Apr 15, 2026 07:30AM
Apr 6, 2026 07:31AM
Apr 6, 2026 07:30AM Medicus Pharma Submits Optimized Phase 2 Study Protocol to U.S. FDA for Teverelix in Acute Urinary Retention
Apr 1, 2026 07:30AM
Apr 1, 2026 07:30AM
Mar 30, 2026 07:30AM
Mar 30, 2026 07:30AM
Mar 26, 2026 07:30AM
Mar 26, 2026 07:30AM
Mar 25, 2026 04:30PM Medicus Pharma Reports Full-Year 2025 Financial Results and Provides Corporate Update
Mar 18, 2026 07:30AM
Mar 18, 2026 07:30AM
Mar 16, 2026 07:30AM
Mar 16, 2026 07:30AM
Mar 10, 2026 07:30AM
Mar 9, 2026 07:30AM
Mar 9, 2026 07:30AM Medicus Pharma Provides Interpretation of Positive Phase 2 SkinJect™ Dataset
Mar 5, 2026 07:30AM

334,268 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All